Capreomycin Sulfate is a polypeptide antibiotic used in combination therapy as a second-line treatment for multidrug-resistant tuberculosis. By binding to bacterial ribosomes, it effectively inhibits protein… Read more
Capreomycin Sulfate is a polypeptide antibiotic used in combination therapy as a second-line treatment for multidrug-resistant tuberculosis. By binding to bacterial ribosomes, it effectively inhibits protein synthesis within Mycobacterium tuberculosis, offering a critical intervention when other primary treatments are insufficient. In pharmaceutical research and development, reference standards of Capreomycin Sulfate, including its identified impurities, metabolites, and stable isotope-labelled compounds, are indispensable tools. These high-quality materials support rigorous analytical testing, including impurity profiling and the validation of chromatographic methods required to ensure drug quality and consistency. Laboratories rely on these compounds for accurate identification and quantification, facilitating compliance with pharmacopeial standards during stability testing, quality control, and routine release analysis of pharmaceutical formulations.